Vialwirebiotech, curated
July 19, 2026, 4:08 AM
July 17, 2026
- 12:00 PM · BioWorld12:00 PMOpen-label extension drives home benefits of Insmed’s PAH therapy — BioWorld
- 12:00 PM · BioWorld12:00 PMDanaher’s Leica to buy Statlab to expand pathology footprint — BioWorld
- 12:00 PM · BioWorld12:00 PMJune’s $25.7B M&A haul caps biopharma’s record-breaking first half — BioWorld
- 10:07 AM · BioPharma Dive10:07 AMArbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advances — BioPharma Dive
- 9:21 AM · BioPharma Dive9:21 AMGSK shelves cough drug acquired in $2B deal — BioPharma Dive
- 9:17 AM · Pharmaceutical Executive9:17 AM<![CDATA[Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement ]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMValerio to collaborate with Abivax, outlines pipeline progress — BioWorld
- 9:00 AM · BioWorld9:00 AMMirador licenses Kira’s long-acting anti-C5a antibody KP-301 — BioWorld
- 6:42 AM · Pharmaceutical Technology6:42 AMBayer’s heart failure drug bound for NHS on NICE recommendation — Pharmaceutical Technology
- 6:18 AM · Pharmaceutical Technology6:18 AMFDA grants traditional approval to Novartis’ Fabhalta for IgAN — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMDNA Script expands access to DNA synthesis platform in India — Drug Discovery World
- 4:30 AM · STAT News